...
首页> 外文期刊>American journal of rhinology >Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient.
【24h】

Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient.

机译:有症状的功能后内窥镜鼻窦手术患者的婴儿洗发水鼻腔冲洗。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Symptoms of postnasal drainage and thickened mucus are commonly seen in patients with chronic rhinosinusitis (CRS) recalcitrant to sinus surgery and conventional medical therapies. Chemical surfactants can act as a mucolytic by reducing water surface tension and have the potential to serve as an antimicrobial agent. Baby shampoo is an inexpensive, commercially available solution containing multiple chemical surfactants. This is an in vitro study of its antimicrobial effects on Pseudomonas biofilms with translation to a clinical study for use as an adjuvant nasal wash in patients with CRS who remain symptomatic despite adequate sinus surgery and conventional medical therapies. METHODS: In vitro testing was performed to determine the optimal concentration of baby shampoo that disrupted preformed bacterial biofilms and inhibited biofilm formation. This concentration was then used in a prospective study of symptomatic post-functional endoscopic sinus surgery (FESS) patients who irrigated twice a day for 4 weeks. Validated outcome forms and objective smell testing was performed before and after therapy. RESULTS: One percent baby shampoo in normal saline was the optimal concentration for inhibition of Pseudomonas biofilm formation. Baby shampoo had no effect on the eradication of preformed Pseudomonas biofilms. Eighteen patients with CRS with an average of 2.8 surgeries were studied after irrigating with 1% baby shampoo solution. Two patients discontinued use because of minor nasal and skin irritations; 46.6% of patients experienced an overall improvement in their subjective symptoms, and 60% of patients noted improvement in specific symptoms of thickened mucus and postnasal drainage. CONCLUSION: Baby shampoo nasal irrigation has promise as an inexpensive, tolerable adjuvant to conventional medical therapies for symptomatic patients after FESS. Its greatest benefit may be in improving symptoms of thickened nasal discharge and postnasal drainage.
机译:背景:鼻窦引流和黏液增厚的症状常见于对鼻窦手术和常规药物治疗无效的慢性鼻-鼻窦炎(CRS)患者。化学表面活性剂可通过降低水的表面张力充当粘液溶解剂,并有潜力用作抗微生物剂。婴儿洗发水是一种便宜的,可商购的,包含多种化学表面活性剂的溶液。这是一项体外研究,其对假单胞菌生物膜具有抗菌作用,并已转化为临床研究,可用于尽管有足够的鼻窦手术和常规药物疗法但仍保持症状的CRS患者的辅助洗鼻液。方法:进行了体外测试,以确定破坏预先形成的细菌生物膜并抑制生物膜形成的婴儿洗发水的最佳浓度。然后将该浓度用于有症状的功能后内窥镜鼻窦手术(FESS)患者的前瞻性研究,这些患者每天进行两次灌溉,持续4周。在治疗前后进行经过验证的结果表格和客观的气味测试。结果:在生理盐水中百分之一的婴儿洗发水是抑制假单胞菌生物膜形成的最佳浓度。婴儿洗发水对根除预先形成的假单胞菌生物膜没有影响。在用1%婴儿洗发水溶液冲洗后,研究了18例平均接受2.8次手术的CRS患者。两名患者由于轻微的鼻腔和皮肤刺激而停止使用。 46.6%的患者主观症状总体得到改善,60%的患者注意到粘液增厚和鼻后引流的特定症状有所改善。结论:婴儿洗发水鼻冲洗液有望成为对FESS后有症状患者进行常规药物治疗的廉价,可耐受的佐剂。其最大的好处可能是改善鼻涕增厚和鼻后引流的症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号